Sherry AD, Lin TA, McCaw ZR, Ludmir EB, et al. Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. Ann Oncol 2024 Jun 3:S0923-7534(24)00718-X. doi: 10.1016/j.annonc.2024.
PMID: 38838846